PMID- 27250889 OWN - NLM STAT- MEDLINE DCOM- 20180920 LR - 20181004 IS - 2078-2101 (Print) IS - 2078-2101 (Linking) VI - 1 IP - 21 DP - 2016 May TI - Efficacy of Different Protocols in Treatment of Nephroblastoma: A revisit. PG - 55-60 AB - BACKGROUND: Management of Nephroblastoma (NB) remains a subject of debate despite the fact that it ranked first among primary childhood's renal neoplasm. We have previously discussed this issue 13, 14, yet, the sample size was limited. AIM: The aim of this study was to further evaluate the efficacy of initial surgery in the treatment of stage II and III pediatric NB as a part of the short administration schedule as in National Wilms' Tumor Study (NWTS)-4 and to evaluate its effectiveness compared to the long administration schedule. PATIENTS AND METHODS: The study included 50 children who were primarily diagnosed as stage II and III NB. They were divided into 2 equal groups. Group I (n = 25) included children who have undergone neoadjuvant chemotherapy followed by surgery and postoperative chemotherapy, while group II (n = 25) included children who have undergone primary surgery as an initial management followed by chemotherapy. After a mean postoperative follow-up period of 20+/-6 months, clinical and radiological evaluation was performed to all patients. RESULTS: In group I, 15 patients were preoperatively diagnosed as stage II and 10 patients as stage III while in group II, 16 patients were proved to be stage II and 9 patients were stage III. After a follow up period, clinical and radiological evaluation using CT was performed to all patients. In patients with stage II, evidence of recurrence was noted in 5 patients of group I whereas no patient showed any evidence of recurrence in group II. In patients with stage III, rebound increase in size was seen in 3 patients in group I and only one patient in group II. CONCLUSIONS: This study confirmed our previous conclusions that initial surgical intervention with appropriate adjuvant therapy has a better outcome than the neoadjuvant chemotherapy and delayed surgery for children primarily diagnosed as stage II and III NB. Moreover, it may also act as a short administration schedule for the treatment as it is not less effective than the long administration schedule and can be administered at a substantially lower total treatment cost. FAU - Zakaria, O M AU - Zakaria OM AD - Department of Surgery, College of Medicine, King Faisal University, Al Ahsa, KSA. AD - Department of Surgery, Faculty of Medicine, Suez Canal University, Egypt. FAU - Daoud, M Y I AU - Daoud MY AD - Department of Surgery, College of Medicine, King Faisal University, Al Ahsa, KSA. FAU - Farrag, S H AU - Farrag SH AD - Department of Surgery, Faculty of Medicine, Suez Canal University, Egypt. FAU - Mulhim, A S AU - Mulhim AS AD - Department of Surgery, College of Medicine, King Faisal University, Al Ahsa, KSA. LA - eng PT - Journal Article PL - Kuwait TA - Gulf J Oncolog JT - The Gulf journal of oncology JID - 101500911 SB - IM MH - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use MH - Child MH - Humans MH - Infant MH - Kidney Neoplasms/*therapy MH - Neoplasm Recurrence, Local MH - Neoplasm Staging MH - Treatment Outcome MH - Wilms Tumor/*therapy OTO - NOTNLM OT - Chemotherapy and Surgery. OT - Children OT - NWTSG4 OT - Nephroblastoma OT - SIOP EDAT- 2016/06/03 06:00 MHDA- 2018/09/21 06:00 CRDT- 2016/06/03 06:00 PHST- 2016/04/15 00:00 [accepted] PHST- 2016/06/03 06:00 [entrez] PHST- 2016/06/03 06:00 [pubmed] PHST- 2018/09/21 06:00 [medline] PST - ppublish SO - Gulf J Oncolog. 2016 May;1(21):55-60.